Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | AR | P10275 | 3/20 | 0.43 |
| ▸ | PGR | P06401 | 2/20 | 0.43 |
| ▸ | EGFR | P00533 | 3/20 | 0.43 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.42 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.42 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.41 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | CHUK | O15111 | 1/20 | 0.39 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.39 |
| ▸ | CASP3 | P42574 | 1/20 | 0.38 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.38 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9608443 | 0.81 | ADORA3 (0.51) | MAPK1SMN1; SMN2ARPGREGFR | |
| SCHEMBL9608399 | 0.80 | MAPK1 (0.40) | MAPK1SMN1; SMN2ARPGRADORA3 | |
| SCHEMBL9608389 | 0.80 | ADORA2A (0.57) | MAPK1SMN1; SMN2ADORA3ALOX15TSHR | |
| SCHEMBL15909991 | 0.80 | ADORA2A (0.57) | MAPK1SMN1; SMN2ADORA3ALOX15TSHR | |
| SCHEMBL9609312 | 0.80 | TSHR (0.53) | MAPK1SMN1; SMN2ARPGRADORA3 | |
| SCHEMBL9608483 | 0.79 | CLK4 (0.53) | MAPK1SMN1; SMN2ADORA3ALOX15TSHR | |
| SCHEMBL15909994 | 0.78 | TSHR (0.49) | MAPK1SMN1; SMN2ARPGREGFR | |
| SCHEMBL15909989 | 0.78 | ADORA3 (0.55) | MAPK1SMN1; SMN2ADORA3ALOX15TSHR | |
| SCHEMBL12250864 | 0.78 | NPC1 (0.45) | SMN1; SMN2ARPGRTSHRADORA2A | |
| SCHEMBL15909992 | 0.78 | CLK4 (0.51) | MAPK1SMN1; SMN2ADORA3ALOX15TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2460799-B1 | NEW TRIAZINE DERIVATIVE, ULTRAVIOLET ABSORBER, AND RESIN COMPOSITION | FUJIFILM CORP (JP) | 2018-05-02 | — | — | EP | disclosed |
| US-20160200933-A1 | RESIN COMPOSITION, PROTECTIVE FILM FOR POLARIZING PLATE, POLARIZING PLATE, AND DISPLAY | FUJIFILM CORPORATION (JP) | 2016-07-14 | — | — | US | disclosed |
| US-8957140-B2 | Triazine derivative, ultraviolet absorber, and resin composition | FUJIFILM CORPORATION (JP) | 2015-02-17 | — | — | US | disclosed |
| US-8748520-B2 | Polycarbonate resin composition containing triazine compound and molded article using the same | FUJIFILM CORPORATION (JP) | 2014-06-10 | — | — | US | disclosed |
| US-8623990-B2 | Polyester resin composition | FUJIFILM CORPORATION (JP) | 2014-01-07 | — | — | US | disclosed |
| EP-2301995-B1 | Polycarbonate resin composition containing triazine compound and molded article using the same | FUJIFILM CORP (JP) | 2013-11-06 | — | — | EP | disclosed |
| US-20120301696-A1 | POLYESTER RESIN COMPOSITION | FUJIFILM CORPORATION (JP) | 2012-11-29 | — | — | US | disclosed |
| EP-2460799-A1 | NEW TRIAZINE DERIVATIVE, ULTRAVIOLET ABSORBER, AND RESIN COMPOSITION | FUJIFILM Corporation (JP) | 2012-06-06 | — | — | EP | disclosed |
| US-20120136098-A1 | NEW TRIAZINE DERIVATIVE, ULTRAVIOLET ABSORBER, AND RESIN COMPOSITION | FUJIFILM CORPORATION (JP) | 2012-05-31 | — | — | US | disclosed |
| US-20110077331-A1 | POLYCARBONATE RESIN COMPOSITION CONTAINING TRIAZINE COMPOUND AND MOLDED ARTICLE USING THE SAME | FUJIFILM CORPORATION (JP) | 2011-03-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120136098-A1 | NEW TRIAZINE DERIVATIVE, ULTRAVIOLET ABSORBER, AND RESIN COMPOSITION | C1R, RPSA, H1-2 | MAPK1 4321/4885SMN1; SMN2 3721/4885AR 2379/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.